| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. | Director | Common Stock | 25,948 | $215,887 | $8.32 | 11 Jun 2025 | Direct |
| Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 11,450 | 11 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | 11 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 16:36 |
| NTLA | Intellia Therapeutics, Inc. | 17 Jun 2024 | 1 | -$37,625 | 4 | Director | 20 Jun 2024, 17:00 |
| NTLA | Intellia Therapeutics, Inc. | 12 Jun 2024 | 2 | $0 | 4 | Director | 14 Jun 2024, 16:22 |
| NTLA | Intellia Therapeutics, Inc. | 14 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:29 |
| NTLA | Intellia Therapeutics, Inc. | 14 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 18:46 |
| NTLA | Intellia Therapeutics, Inc. | 23 Jun 2021 | 2 | $0 | 4 | Director | 25 Jun 2021, 18:14 |